Pediatric
Ethics Subcommittee of the Pediatric Advisory Committee
DoubleTree Hotel, Regency
Room
1750 Rockville Pike,
Rockville, Maryland 20852
"Effects of a Single
Dose of Dextroamphetamine in Attention Deficit Hyperactivity Disorder; A
Functional Magnetic Resonance Study "
8:30 Call to Order, Introductions Robert M. Nelson, M.D., Ph.D.
Chair, Pediatric Ethics Subcommittee
Meeting Statement Jan N.
Johannessen, Ph.D.
Executive Secretary
8:40 Subpart D Expert Panel Process Bernard
Schwetz, D.V.M, Ph.D.
Director, Office for Human Research Protections
Sara Goldkind, M.D,. M.A.
Bioethicist, Office of Pediatric Therapeutics, FDA
9:00 Overview, Charge to Panel and Final Outcome Robert M. Nelson, M.D., Ph.D.
Chair, Pediatric Ethics Subcommittee
9:20 Background on ADHD/Protocol Overview Judith L. Rapoport, M.D.
Principal
Investigator, NIMH, NIH
9:40 IRB Questions Pediatric Ethics Subcommittee
Donald
L. Rosenstein, M.D.
Chair, NIH IRB
10:00 Break
10:15 Summary of Submitted Public Comments Robert M. Nelson, M.D., Ph.D.
Chair, Pediatric Ethics Subcommittee
10:30 Questions and Panel Discussion Subcommittee
Members
11:00 Open Public Hearing
12:00 Lunch
1:00 Questions and Panel Discussion Subcommittee Members
2:30 Break
2:45 Summary of the Deliberations Robert M. Nelson, M.D., Ph.D.
Chair, Pediatric Ethics Subcommittee
3:30 Close